Clinical Trial Update: Low Versus High Dose OnabotulinumtoxinA for Chronic Anal Fissure [Phase 3]

View source ↗

Summary

This Phase 3 trial compared low-dose versus high-dose onabotulinumtoxinA for chronic anal fissure and has completed. The update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Fissure

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Tanta University | Conditions: Chronic Anal Fissure | Phase 3 | Status: COMPLETED